#begin document (nw/wsj/23/wsj_2382); part 000
nw/wsj/23/wsj_2382   0    0               Food    NNP  (TOP(S(NP(NML(NML(NML*         -    -    -   -      (ORG*   (ARG0*        *             *        *   -
nw/wsj/23/wsj_2382   0    1                and     CC                       *         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0    2               Drug    NNP                       *)        -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0    3     Administration    NNP                       *)        -    -    -   -          *)       *        *             *        *   -
nw/wsj/23/wsj_2382   0    4          spokesman     NN                       *)        -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0    5               Jeff    NNP                       *         -    -    -   -   (PERSON*        *        *             *        *   -
nw/wsj/23/wsj_2382   0    6             Nesbit    NNP                       *)        -    -    -   -          *)       *)       *             *        *   -
nw/wsj/23/wsj_2382   0    7               said    VBD                    (VP*        say  01    1   -          *      (V*)       *             *        *   -
nw/wsj/23/wsj_2382   0    8                the     DT             (SBAR(S(NP*         -    -    -   -          *   (ARG1*   (ARG0*        (ARG0*        *   -
nw/wsj/23/wsj_2382   0    9             agency     NN                       *)        -    -    -   -          *        *        *)            *)       *   -
nw/wsj/23/wsj_2382   0   10                has    VBZ                    (VP*       have  03    -   -          *        *      (V*)            *        *   -
nw/wsj/23/wsj_2382   0   11             turned    VBN                    (VP*       turn  12   11   -          *        *   (ARG1*           (V*)       *   -
nw/wsj/23/wsj_2382   0   12               over     RP                   (PRT*)        -    -    -   -          *        *        *    (ARGM-DIR*)       *   -
nw/wsj/23/wsj_2382   0   13           evidence     NN                 (NP(NP*)        -    -    3   -          *        *        *        (ARG1*        *   -
nw/wsj/23/wsj_2382   0   14                 in     IN                    (PP*         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   15                  a     DT                 (NP(NP*         -    -    -   -          *        *        *             *   (ARG0*   -
nw/wsj/23/wsj_2382   0   16           criminal     JJ                       *         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   17      investigation     NN                       *)        -    -    1   -          *        *        *             *        *)  -
nw/wsj/23/wsj_2382   0   18         concerning    VBG                    (VP*    concern  02    1   -          *        *        *             *      (V*)  -
nw/wsj/23/wsj_2382   0   19           Vitarine    NNP                    (NP*         -    -    -   -      (ORG*        *        *             *   (ARG1*   -
nw/wsj/23/wsj_2382   0   20    Pharmaceuticals   NNPS                       *         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   21               Inc.    NNP                   *)))))        -    -    -   -          *)       *        *             *)       *)  -
nw/wsj/23/wsj_2382   0   22                 to     IN                    (PP*         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   23                the     DT              (NP(NP(NP*         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   24               U.S.    NNP                       *         -    -    -   -       (GPE)       *        *             *        *   -
nw/wsj/23/wsj_2382   0   25           Attorney    NNP                       *         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   26                 's    POS                       *)        -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   27             office     NN                       *)        -    -    5   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   28                 in     IN                    (PP*         -    -    -   -          *        *        *             *        *   -
nw/wsj/23/wsj_2382   0   29          Baltimore    NNP            (NP*)))))))))        -    -    -   -       (GPE)       *)       *)            *        *   -
nw/wsj/23/wsj_2382   0   30                  .      .                      *))        -    -    -   -          *        *        *             *        *   -

nw/wsj/23/wsj_2382   0    0        Neither    CC  (TOP(S(NP*        -    -   -   -       *   (ARG0*   (ARG1*   (ARG1*   -
nw/wsj/23/wsj_2382   0    1       Vitarine   NNP        (NP*)       -    -   -   -    (ORG)       *        *        *   -
nw/wsj/23/wsj_2382   0    2            nor    CC           *        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0    3            any    DT     (NP(NP*)       -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0    4             of    IN        (PP*        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0    5            the    DT     (NP(NP*        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0    6    Springfield   NNP       (NML*        -    -   -   -   (GPE*        *        *        *   -
nw/wsj/23/wsj_2382   0    7        Gardens   NNP           *        -    -   -   -       *)       *        *        *   -
nw/wsj/23/wsj_2382   0    8              ,     ,           *        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0    9           N.Y.   NNP           *        -    -   -   -    (GPE)       *        *        *   -
nw/wsj/23/wsj_2382   0   10              ,     ,           *)       -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   11        company    NN           *        -    -   1   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   12             's   POS           *)       -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   13      officials   NNS           *        -    -   1   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   14             or    CC           *        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   15      employees   NNS        *))))       -    -   -   -       *        *)       *)       *)  -
nw/wsj/23/wsj_2382   0   16           have   VBP        (VP*      have  03   -   -       *      (V*)       *        *   -
nw/wsj/23/wsj_2382   0   17           been   VBN        (VP*        be  01   -   -       *   (ARG1*      (V*)       *   -
nw/wsj/23/wsj_2382   0   18        charged   VBN        (VP*    charge  05   3   -       *        *   (ARG2*      (V*)  -
nw/wsj/23/wsj_2382   0   19           with    IN        (PP*        -    -   -   -       *        *        *   (ARG2*   -
nw/wsj/23/wsj_2382   0   20            any    DT        (NP*        -    -   -   -       *        *        *        *   -
nw/wsj/23/wsj_2382   0   21         crimes   NNS       *)))))       -    -   1   -       *        *)       *)       *)  -
nw/wsj/23/wsj_2382   0   22              .     .          *))       -    -   -   -       *        *        *        *   -

nw/wsj/23/wsj_2382   0    0        Vitarine    NNP   (TOP(S(NP*)           -    -   -   -    (ORG)   (ARG0*)   (ARG0*)           *   -
nw/wsj/23/wsj_2382   0    1             won    VBD      (VP(VP*           win  01   2   -       *       (V*)        *            *   -
nw/wsj/23/wsj_2382   0    2        approval     NN         (NP*            -    -   -   -       *    (ARG1*         *            *   -
nw/wsj/23/wsj_2382   0    3              to     TO       (S(VP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    4          market     VB         (VP*        market  01   -   -       *         *       (V*)           *   -
nw/wsj/23/wsj_2382   0    5               a     DT      (NP(NP*            -    -   -   -       *         *    (ARG1*            *   -
nw/wsj/23/wsj_2382   0    6         version     NN            *)           -    -   2   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    7              of     IN         (PP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    8               a     DT         (NP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    9           blood     NN        (NML*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   10        pressure     NN            *)           -    -   1   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   11        medicine     NN     *))))))))           -    -   1   -       *         *)        *)           *   -
nw/wsj/23/wsj_2382   0   12             but     CC            *            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   13    acknowledged    VBD         (VP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   14            that     IN       (SBAR*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   15              it    PRP       (S(NP*)           -    -   -   -       *         *         *       (ARG0*)  -
nw/wsj/23/wsj_2382   0   16     substituted    VBN         (VP*    substitute  01   -   -       *         *         *          (V*)  -
nw/wsj/23/wsj_2382   0   17               a     DT         (NP*            -    -   -   -       *         *         *       (ARG1*   -
nw/wsj/23/wsj_2382   0   18      SmithKline    NNP        (NML*            -    -   -   -   (ORG*         *         *            *   -
nw/wsj/23/wsj_2382   0   19         Beecham    NNP            *            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   20             PLC    NNP            *)           -    -   -   -       *)        *         *            *   -
nw/wsj/23/wsj_2382   0   21         product     NN            *)           -    -   1   -       *         *         *            *)  -
nw/wsj/23/wsj_2382   0   22              as     IN         (PP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   23             its   PRP$         (NP*            -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   24             own     JJ           *))           -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   25              in     IN         (PP*            -    -   -   -       *         *         *   (ARGM-LOC*   -
nw/wsj/23/wsj_2382   0   26           tests    NNS   (NP*)))))))           -    -   1   -       *         *         *            *)  -
nw/wsj/23/wsj_2382   0   27               .      .           *))           -    -   -   -       *         *         *            *   -

nw/wsj/23/wsj_2382   0    0               Mr.    NNP   (TOP(S(NP*        -    -   -   -          *        (ARG0*        *        *            *   -
nw/wsj/23/wsj_2382   0    1            Nesbit    NNP            *)       -    -   -   -    (PERSON)            *)       *        *            *   -
nw/wsj/23/wsj_2382   0    2              also     RB       (ADVP*)       -    -   -   -          *    (ARGM-DIS*)       *        *            *   -
nw/wsj/23/wsj_2382   0    3              said    VBD         (VP*       say  01   1   -          *           (V*)       *        *            *   -
nw/wsj/23/wsj_2382   0    4               the     DT  (SBAR(S(NP*        -    -   -   -          *        (ARG1*   (ARG0*   (ARG0*            *   -
nw/wsj/23/wsj_2382   0    5               FDA    NNP            *)       -    -   -   -       (ORG)            *        *)       *)           *   -
nw/wsj/23/wsj_2382   0    6               has    VBZ         (VP*      have  03   -   -          *             *      (V*)       *            *   -
nw/wsj/23/wsj_2382   0    7             asked    VBN         (VP*       ask  02   2   -          *             *   (ARG1*      (V*)           *   -
nw/wsj/23/wsj_2382   0    8             Bolar    NNP         (NP*        -    -   -   -      (ORG*             *        *   (ARG2*       (ARG0*   -
nw/wsj/23/wsj_2382   0    9    Pharmaceutical    NNP            *        -    -   -   -          *             *        *        *            *   -
nw/wsj/23/wsj_2382   0   10               Co.    NNP            *)       -    -   -   -          *)            *        *        *)           *)  -
nw/wsj/23/wsj_2382   0   11                to     TO       (S(VP*        -    -   -   -          *             *        *   (ARG1*            *   -
nw/wsj/23/wsj_2382   0   12            recall     VB         (VP*    recall  01   2   -          *             *        *        *          (V*)  -
nw/wsj/23/wsj_2382   0   13                at     IN         (PP*        -    -   -   -          *             *        *        *   (ARGM-LOC*   -
nw/wsj/23/wsj_2382   0   14               the     DT         (NP*        -    -   -   -          *             *        *        *            *   -
nw/wsj/23/wsj_2382   0   15            retail     JJ            *        -    -   -   -          *             *        *        *            *   -
nw/wsj/23/wsj_2382   0   16             level     NN           *))       -    -   2   -          *             *        *        *            *)  -
nw/wsj/23/wsj_2382   0   17               its   PRP$         (NP*        -    -   -   -          *             *        *        *       (ARG1*   -
nw/wsj/23/wsj_2382   0   18           urinary     JJ            *        -    -   -   -          *             *        *        *            *   -
nw/wsj/23/wsj_2382   0   19             tract     NN            *        -    -   2   -          *             *        *        *            *   -
nw/wsj/23/wsj_2382   0   20        antibiotic     NN    *)))))))))       -    -   -   -          *             *)       *)       *)           *)  -
nw/wsj/23/wsj_2382   0   21                 .      .           *))       -    -   -   -          *             *        *        *            *   -

nw/wsj/23/wsj_2382   0    0          But    CC  (TOP(S(S*        -    -   -   -   *    (ARGM-DIS*)   (ARGM-DIS*)  (ARG1*   -
nw/wsj/23/wsj_2382   0    1           so    RB     (ADVP*        -    -   -   -   *    (ARGM-TMP*    (ARGM-TMP*        *   -
nw/wsj/23/wsj_2382   0    2          far    RB          *)       -    -   -   -   *             *)            *)       *   -
nw/wsj/23/wsj_2382   0    3          the    DT       (NP*        -    -   -   -   *        (ARG0*        (ARG0*        *   -
nw/wsj/23/wsj_2382   0    4      company    NN          *)       -    -   1   -   *             *)            *)       *   -
nw/wsj/23/wsj_2382   0    5          has   VBZ       (VP*      have  03   -   -   *           (V*)            *        *   -
nw/wsj/23/wsj_2382   0    6          n't    RB          *        -    -   -   -   *             *    (ARGM-NEG*)       *   -
nw/wsj/23/wsj_2382   0    7     complied   VBN       (VP*    comply  01   -   -   *    (ARGM-ADV*           (V*)       *   -
nw/wsj/23/wsj_2382   0    8         with    IN       (PP*        -    -   -   -   *             *        (ARG1*        *   -
nw/wsj/23/wsj_2382   0    9         that    DT       (NP*        -    -   -   -   *             *             *        *   -
nw/wsj/23/wsj_2382   0   10      request    NN      *)))))       -    -   1   -   *             *)            *)       *)  -
nw/wsj/23/wsj_2382   0   11            ,     ,          *        -    -   -   -   *             *             *        *   -
nw/wsj/23/wsj_2382   0   12          the    DT       (NP*        -    -   -   -   *             *             *   (ARG0*   -
nw/wsj/23/wsj_2382   0   13    spokesman    NN          *)       -    -   -   -   *             *             *        *)  -
nw/wsj/23/wsj_2382   0   14         said   VBD       (VP*)      say  01   1   -   *             *             *      (V*)  -
nw/wsj/23/wsj_2382   0   15            .     .         *))       -    -   -   -   *             *             *        *   -

nw/wsj/23/wsj_2382   0    0            Bolar    NNP   (TOP(S(S(NP(NP*)       -    -   -   -         (ORG)       (ARG0*   (ARG0*      (ARG1*   -
nw/wsj/23/wsj_2382   0    1                ,      ,                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    2              the     DT           (NP(NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    3          subject     NN                 *)       -    -   1   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    4               of     IN              (PP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    5                a     DT           (NP(NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    6         criminal     JJ                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    7    investigation     NN                 *)       -    -   1   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    8               by     IN              (PP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0    9              the     DT           (NP(NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   10              FDA    NNP                 *)       -    -   -   -         (ORG)            *        *           *   -
nw/wsj/23/wsj_2382   0   11              and     CC                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   12              the     DT        (NP(NP(NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   13        Inspector    NNP                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   14          General    NNP                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   15               's    POS                 *)       -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   16           office     NN                 *)       -    -   5   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   17               of     IN              (PP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   18              the     DT              (NP*        -    -   -   -        (ORG*             *        *           *   -
nw/wsj/23/wsj_2382   0   19           Health    NNP         (NML(NML*)       -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   20              and     CC                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   21            Human    NNP             (NML*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   22         Services    NNP                *))       -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   23       Department    NNP          *))))))))       -    -   -   -            *)            *        *           *   -
nw/wsj/23/wsj_2382   0   24                ,      ,                 *)       -    -   -   -            *             *)       *)          *   -
nw/wsj/23/wsj_2382   0   25             only     RB            (ADVP*)       -    -   -   -            *    (ARGM-ADV*)       *           *   -
nw/wsj/23/wsj_2382   0   26           agreed    VBD              (VP*     agree  01   3   -            *           (V*)       *           *   -
nw/wsj/23/wsj_2382   0   27               to     TO            (S(VP*        -    -   -   -            *        (ARG1*        *           *   -
nw/wsj/23/wsj_2382   0   28           recall     VB              (VP*    recall  01   2   -            *             *      (V*)          *   -
nw/wsj/23/wsj_2382   0   29              two     CD           (NP(NP*        -    -   -   -    (CARDINAL)            *   (ARG1*           *   -
nw/wsj/23/wsj_2382   0   30        strengths    NNS                 *)       -    -   6   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   31               of     IN              (PP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   32              its   PRP$           (NP(NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   33          version     NN                 *)       -    -   2   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   34               of     IN              (PP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   35      Macrodantin    NNP          (NP*)))))       -    -   -   -     (PRODUCT)            *        *)          *   -
nw/wsj/23/wsj_2382   0   36               ``     ``            (ADVP*        -    -   -   -            *             *   (ARG2*           *   -
nw/wsj/23/wsj_2382   0   37               as     RB       (ADVP(ADVP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   38              far     RB                 *)       -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   39             down     RB                 *)       -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   40               as     IN            (SBAR*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   41           direct     JJ              (NP*        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   42        customers    NNS                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   43                ,      ,                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   44           mostly     RB                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   45      wholesalers    NNS          *))))))))       -    -   -   -            *             *)       *)          *)  -
nw/wsj/23/wsj_2382   0   46                ,      ,                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   47               ''     ''                 *        -    -   -   -            *             *        *           *   -
nw/wsj/23/wsj_2382   0   48              Mr.    NNP              (NP*        -    -   -   -            *             *        *      (ARG0*   -
nw/wsj/23/wsj_2382   0   49           Nesbit    NNP                 *)       -    -   -   -      (PERSON)            *        *           *)  -
nw/wsj/23/wsj_2382   0   50             said    VBD              (VP*)      say  01   1   -            *             *        *         (V*)  -
nw/wsj/23/wsj_2382   0   51                .      .                *))       -    -   -   -            *             *        *    (C-ARG1*)  -

nw/wsj/23/wsj_2382   0    0        Bolar    NNP   (TOP(S(NP(NP*)      -    -   -   -         (ORG)       (ARG0*   -
nw/wsj/23/wsj_2382   0    1            ,      ,               *       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0    2           of     IN            (PP*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0    3     Copiague    NNP         (NP(NP*)      -    -   -   -         (GPE)            *   -
nw/wsj/23/wsj_2382   0    4            ,      ,               *       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0    5         N.Y.    NNP          (NP*)))      -    -   -   -         (GPE)            *   -
nw/wsj/23/wsj_2382   0    6            ,      ,               *)      -    -   -   -            *             *)  -
nw/wsj/23/wsj_2382   0    7      earlier    RBR          (ADVP*)      -    -   -   -            *    (ARGM-TMP*)  -
nw/wsj/23/wsj_2382   0    8        began    VBD            (VP*    begin  01   2   -            *           (V*)  -
nw/wsj/23/wsj_2382   0    9            a     DT         (NP(NP*       -    -   -   -            *        (ARG1*   -
nw/wsj/23/wsj_2382   0   10    voluntary     JJ               *       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   11       recall     NN               *)      -    -   1   -            *             *   -
nw/wsj/23/wsj_2382   0   12           of     IN            (PP*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   13         both    PDT         (NP(NP*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   14          its   PRP$               *       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   15         100      CD       (NML(NML*       -    -   -   -   (QUANTITY*             *   -
nw/wsj/23/wsj_2382   0   16    milligram     NN               *)      -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   17          and     CC               *       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   18          50      CD           (NML*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   19    milligram     NN              *))      -    -   -   -            *)            *   -
nw/wsj/23/wsj_2382   0   20     versions    NNS               *)      -    -   2   -            *             *   -
nw/wsj/23/wsj_2382   0   21           of     IN            (PP*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   22          the     DT            (NP*       -    -   -   -            *             *   -
nw/wsj/23/wsj_2382   0   23         drug     NN          *))))))      -    -   1   -            *             *)  -
nw/wsj/23/wsj_2382   0   24            .      .              *))      -    -   -   -            *             *   -

nw/wsj/23/wsj_2382   0    0            The     DT                     (TOP(S(NP*            -    -   -   -           *   (ARG0*   (ARG0*         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0    1            FDA    NNP                              *)           -    -   -   -        (ORG)       *)       *)        *            *        *         *        *   -
nw/wsj/23/wsj_2382   0    2            has    VBZ                           (VP*          have  03   -   -           *      (V*)       *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0    3           said    VBD                           (VP*           say  01   1   -           *        *      (V*)        *            *        *         *        *   -
nw/wsj/23/wsj_2382   0    4             it    PRP                    (SBAR(S(NP*)           -    -   -   -           *        *   (ARG1*    (ARG0*)           *        *         *        *   -
nw/wsj/23/wsj_2382   0    5      presented    VBD                           (VP*       present  01   2   -           *        *        *       (V*)           *        *         *        *   -
nw/wsj/23/wsj_2382   0    6       evidence     NN                           (NP*            -    -   1   -           *        *        *    (ARG1*            *        *         *        *   -
nw/wsj/23/wsj_2382   0    7             it    PRP                    (SBAR(S(NP*)           -    -   -   -           *        *        *         *       (ARG0*)       *         *        *   -
nw/wsj/23/wsj_2382   0    8      uncovered    VBD                           (VP*       uncover  01   1   -           *        *        *         *          (V*)       *         *        *   -
nw/wsj/23/wsj_2382   0    9             to     IN                           (PP*            -    -   -   -           *        *        *         *       (ARG1*        *         *        *   -
nw/wsj/23/wsj_2382   0   10            the     DT                           (NP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   11        company     NN                             *))           -    -   1   -           *        *        *         *            *)       *         *        *   -
nw/wsj/23/wsj_2382   0   12     indicating    VBG                         (S(VP*      indicate  01   1   -           *        *        *         *   (ARGM-ADV*      (V*)        *        *   -
nw/wsj/23/wsj_2382   0   13           that     IN                         (SBAR*            -    -   -   -           *        *        *         *            *   (ARG1*         *        *   -
nw/wsj/23/wsj_2382   0   14          Bolar    NNP                         (S(NP*)           -    -   -   -        (ORG)       *        *         *            *        *    (ARG0*)       *   -
nw/wsj/23/wsj_2382   0   15    substituted    VBN                           (VP*    substitute  01   -   -           *        *        *         *            *        *       (V*)       *   -
nw/wsj/23/wsj_2382   0   16            the     DT                        (NP(NP*            -    -   -   -           *        *        *         *            *        *    (ARG1*        *   -
nw/wsj/23/wsj_2382   0   17          brand     NN                          (NML*            -    -   1   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   18             -    HYPH                              *            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   19           name     NN                              *)           -    -   1   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   20        product     NN                              *)           -    -   1   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   21            for     IN                           (PP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   22            its   PRP$                           (NP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   23            own     JJ                            *)))           -    -   -   -           *        *        *         *            *        *         *)       *   -
nw/wsj/23/wsj_2382   0   24             to     TO                         (S(VP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   25           gain     VB                           (VP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   26     government     NN                        (NP(NP*            -    -   1   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   27       approval     NN                              *)           -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   28             to     TO                    (SBAR(S(VP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   29           sell     VB                           (VP*          sell  01   1   -           *        *        *         *            *        *         *      (V*)  -
nw/wsj/23/wsj_2382   0   30        generic     JJ                        (NP(NP*            -    -   -   -           *        *        *         *            *        *         *   (ARG1*   -
nw/wsj/23/wsj_2382   0   31       versions    NNS                              *)           -    -   2   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   32             of     IN                           (PP*            -    -   -   -           *        *        *         *            *        *         *        *   -
nw/wsj/23/wsj_2382   0   33    Macrodantin    NNP   (NP*)))))))))))))))))))))))))           -    -   -   -    (PRODUCT)       *        *)        *)           *)       *)        *        *)  -
nw/wsj/23/wsj_2382   0   34              .      .                             *))           -    -   -   -           *        *        *         *            *        *         *        *   -

nw/wsj/23/wsj_2382   0    0       Bolar    NNP   (TOP(S(NP*)       -    -   -   -    (ORG)   (ARG0*)   (ARG0*)           *   -
nw/wsj/23/wsj_2382   0    1         has    VBZ         (VP*      have  03   -   -       *       (V*)        *            *   -
nw/wsj/23/wsj_2382   0    2      denied    VBN         (VP*      deny  01   1   -       *    (ARG1*       (V*)           *   -
nw/wsj/23/wsj_2382   0    3        that     IN       (SBAR*        -    -   -   -       *         *    (ARG1*            *   -
nw/wsj/23/wsj_2382   0    4          it    PRP       (S(NP*)       -    -   -   -       *         *         *       (ARG0*)  -
nw/wsj/23/wsj_2382   0    5    switched    VBD         (VP*    switch  01   1   -       *         *         *          (V*)  -
nw/wsj/23/wsj_2382   0    6         the     DT         (NP*        -    -   -   -       *         *         *       (ARG1*   -
nw/wsj/23/wsj_2382   0    7       brand     NN        (NML*        -    -   1   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    8          -    HYPH            *        -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0    9        name     NN            *)       -    -   1   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   10     product     NN            *)       -    -   1   -       *         *         *            *)  -
nw/wsj/23/wsj_2382   0   11         for     IN         (PP*        -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   12         its   PRP$         (NP*        -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   13         own     JJ           *))       -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   14          in     IN         (PP*        -    -   -   -       *         *         *   (ARGM-LOC*   -
nw/wsj/23/wsj_2382   0   15        such     JJ         (NP*        -    -   -   -       *         *         *            *   -
nw/wsj/23/wsj_2382   0   16     testing     NN      *)))))))       -    -   1   -       *         *)        *)           *)  -
nw/wsj/23/wsj_2382   0   17           .      .           *))       -    -   -   -       *         *         *            *   -

#end document
